Therapeutic viruses have huge potential yet cannot currently be delivered intravenously, being limited to intratumoral injection. This restricts their clinical use.
Our pioneering platform is designed to relieve this crucial barrier that prevents systemic delivery. This allows our cancer-killing virus to deliver medicinal payloads within the tumour to stimulate and reprogram the immune system to attack and destroy cancer.
We use cookies to analyze website traffic and optimize your website experience and not for advertising. By accepting our use of cookies, your data will be aggregated with all other user data. We value transparency and a link to our privacy policy can be found on our Contact Us page.